Acutus Medical Inc. (AFIB)
OTC: AFIB
· Real-Time Price · USD
0.04
-0.00 (-4.76%)
At close: Apr 04, 2025, 3:23 PM
Acutus Medical Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 7.14M | 5.27M | 4.13M | 3.63M | -7.53M | 5.24M | 5.29M | 1.24M | 4.96M | 3.64M | 4.08M | 3.68M | 4.36M | 4.6M | 4.71M | 3.59M |
Cost of Revenue | 6.13M | 4.89M | 4.47M | 3.65M | -13.15M | 8.6M | 8.06M | 2.11M | 8.32M | 6.95M | 9.7M | 6.94M | 9.94M | 8.54M | 7.49M | 6.96M |
Gross Profit | 1.01M | 372K | -343K | -30K | 5.61M | -3.36M | -2.77M | -869K | -3.36M | -3.31M | -5.62M | -3.26M | -5.58M | -3.94M | -2.78M | -3.36M |
Operating Income | -272K | 489K | 301K | -575K | 35.69M | -12.94M | -17.17M | -5.27M | 16.82M | -20.46M | 14.93M | -38.63M | -29.9M | -27.09M | -27.3M | -27.83M |
Interest Income | 122K | 153K | 207K | 281K | 365K | 547K | 824K | 853K | 576K | 241K | 27K | 24K | 28K | 19K | 29K | 40K |
Pretax Income | -1.3M | -816K | -362K | -2.06M | 35.97M | -13.16M | -18.35M | -4.28M | 15.19M | -20.43M | 5.72M | -40.02M | -31.26M | -28.51M | -28.73M | -29.18M |
Net Income | -1.41M | -5.61M | -914K | -1.62M | -33.77M | -13.24M | -18.35M | -16.32M | 15.11M | -20.39M | -3.49M | -41.4M | -31.26M | -28.51M | -28.73M | -29.18M |
Selling & General & Admin | 2.56M | 2.32M | 2.23M | 3.34M | -12.21M | 7.43M | 9.28M | 4.47M | 9.45M | 9.68M | 14.14M | 14.38M | 15.87M | 15.8M | 15.6M | 16.25M |
Research & Development | n/a | n/a | n/a | n/a | -14.23M | 4.79M | 6.8M | 938K | 6.27M | 5.95M | 7.93M | 8M | 8.84M | 9.3M | 9.17M | 9.37M |
Other Expenses | -6.93M | -2.44M | n/a | n/a | n/a | n/a | n/a | -1.01M | n/a | 1.53M | n/a | 12.98M | 9.56M | 6.59M | n/a | n/a |
Operating Expenses | -1.51M | -117K | -644K | 3.34M | -26.44M | 12.23M | 16.08M | 4.4M | 15.72M | 15.63M | 22.08M | 22.39M | 24.7M | 25.1M | 24.77M | 25.62M |
Interest Expense | 1.38M | 1.4M | 1.51M | 1.48M | 1.54M | 1.41M | 1.4M | 1.31M | 1.34M | 1.11M | 1.29M | 1.41M | 1.39M | 1.44M | 1.46M | 1.39M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.75M | 4.78M | 6.7M | 6.99M | -39.59M | 20.82M | 24.15M | 6.51M | 24.04M | 22.58M | 31.77M | 29.33M | 34.64M | 33.64M | 32.27M | 32.58M |
Income Tax Expense | -4.78M | 4.79M | n/a | -10K | -12K | 75K | 1.4M | n/a | 82K | -36K | 9.21M | 1.39M | 1.39M | 1.44M | 1.46M | 1.39M |
Shares Outstanding (Basic) | 29.77M | 29.8M | 29.72M | 29.69M | 29.26M | 29.26M | 29.04M | 28.76M | 28.47M | 28.36M | 28.34M | 28.12M | 27.95M | 30.46M | 28.15M | 28.03M |
Shares Outstanding (Diluted) | 29.77M | 29.8M | 29.72M | 29.69M | 29.26M | 29.26M | 29.04M | 28.76M | 37.24M | 28.36M | 28.35M | 28.12M | 27.95M | 30.46M | 28.15M | 28.03M |
EPS (Basic) | -0.04 | -0.19 | -0.03 | -0.05 | 0.26 | -0.45 | -0.63 | -0.57 | 0.53 | -0.72 | 0.16 | -1.42 | -1.12 | -0.94 | -1.02 | -1.04 |
EPS (Diluted) | -0.04 | -0.19 | -0.03 | -0.05 | 0.26 | -0.45 | -0.63 | -0.57 | 0.41 | -0.72 | 0.16 | -1.42 | -1.12 | -0.94 | -1.02 | -1.04 |
EBITDA | 322K | 836K | 1.4M | -313K | 32.42M | -12.94M | -16.63M | -2.72M | 18.16M | -17.37M | 8.91M | -36.72M | -28.18M | -25.28M | -25.7M | -26.21M |
EBIT | 72K | 579K | 1.15M | -577K | 37.51M | -11.75M | -2.84M | -2.97M | 16.53M | -19.32M | 7.01M | -38.61M | -29.87M | -27.07M | -27.27M | -27.79M |
Depreciation & Amortization | 250K | 257K | 256K | 264K | -3.29M | 1.3M | 1.45M | 257K | 1.63M | 1.72M | 1.94M | 1.89M | 1.69M | 1.85M | 1.82M | 1.58M |